Condition: Osteoarthritis, Knee · Sponsor: Paradigm Biopharmaceuticals Ltd.
The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee OA pain. Study details include: * The study duration will be up to 64 weeks. * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit/contact frequency will be every 4-6 weeks during the 52-week Follow-up period. * Approximately 466 participants will be enrolled into this study.
This description comes directly from the study's public registry record.
Donna Skerrett · +1 (312) 771 9615 · info@paradigmbiopharma.com
Always discuss trial participation with your own doctor first.
| Onyx Clinical Research-Peoria | Peoria, Arizona, United States | Recruiting |
| Del Sol Research Management, LLC | Tucson, Arizona, United States | Recruiting |
| Orange County Research Institute | Anaheim, California, United States | Recruiting |
| Core Healthcare Group | Cerritos, California, United States | Recruiting |
| Triwest Research Center | Chula Vista, California, United States | Recruiting |
| Seaside Medical Group | Oceanside, California, United States | Recruiting |
| Paragon RX Clinical | Santa Ana, California, United States | Recruiting |
| Encompass Clinical Research | Spring Valley, California, United States | Recruiting |
| Focus Clinical Research | West Hills, California, United States | Recruiting |
| Clinical Research of West Florida - Clearwater | Clearwater, Florida, United States | Recruiting |
| GNP Research | Cooper City, Florida, United States | Recruiting |
| Arrow Clinical Trials | Daytona Beach, Florida, United States | Recruiting |
+ 44 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.